Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive. - Investor's Business Daily

1. Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.  Investor's Business Daily
2. Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs  The Wall Street Journal
3. Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s  CNBC
4. GLP-1 stocks wilt following Trump comments  Axios
5. Trump says Ozempic prices will be 'much lower' for Americans  Fox Business